Vaccine Therapy in Treating Patients With Melanoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 2000

Study Completion Date

October 31, 2007

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL

aldesleukin

BIOLOGICAL

gp100 antigen

BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

tyrosinase peptide

Trial Locations (1)

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00020358 - Vaccine Therapy in Treating Patients With Melanoma | Biotech Hunter | Biotech Hunter